Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT00166036
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
36
Enrollment(s)
1
Study location(s)
Interventional (Phase II)
Diabetes Mellitus
Metabolic Syndrome X
Hypercholesterolemia
Completed
NCT02229773
Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects
100
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Healthy
Unknown status
NCT02221102
Edoxaban for TIA and Acute Minor Stroke
3,700
Enrollment(s)
1
Study location(s)
Interventional (Phase II|Phase III)
Ischemia
Stroke
Cerebral Infarction
Completed
NCT01839968
Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel
32
Enrollment(s)
1
Study location(s)
Observational
Acquired Platelet Disorder
Completed
NCT01602913
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
1
Enrollment(s)
0
Study location(s)
Observational
Depression, Postpartum
Completed
NCT02045966
Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects
16
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Hepatitis C
Completed
NCT00630734
Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin
32
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
HIV Infections
Hyperlipidemia
Completed
NCT00417222
Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan
1,145
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Chronic Heart Failure
81
82
83
84
85